Q-omics provides the consensus-scored RNU6-232P profile across patient tissues and cancer cell-line models. RNU6-232P expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in ESCA. Additionally, RNU6-232P RNA expression shows 5,719 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight ESCA, and STAD as cancer lineages where RNU6-232P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNU6-232P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNU6-232P survival associations across molecular data types. RNU6-232P RNA expression shows survival associations in the most cancer types (7). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-232P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	7	ESCA (36)	view →

This table ranks reproducible RNU6-232P RNA expression–survival associations across cancer types. High RNU6-232P expression shows unfavorable associations in ESCA, STAD, BRCA, LUAD, LIHC and KIRC. The ESCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .010). Together, the overview and detailed table identify ESCA as the clearest survival context for RNU6-232P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Tertile	II,III,IV	0.254	0.535	.010	36	view →
STAD	DFS	Tertile	All	0.129	0.539	<.001	36	view →
BRCA	DFS	Tertile	III,IV	0.141	0.796	<.001	18	view →
LUAD	DFS	Tertile	II,III,IV	0.178	0.721	.008	18	view →
LIHC	OS	Tertile	All	0.183	0.690	.003	18	view →
KIRC	OS	Tertile	All	0.628	0.808	.045	12	view →

Pink = unfavorable, green = favorable. all 7 lineages →

RNU6-232P-ESCA (DFS)

Kaplan–Meier survival curve for RNU6-232P RNA expression in ESCA: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNU6-232P in patient tissues and cancer cell lines. In patient samples, RNU6-232P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	5,719	STAD (5595)	view →
RNA	5,306	COAD (1891)	view →